Literature DB >> 17972349

The T cell antigen receptor: "The Hunting of the Snark".

Tak W Mak1.   

Abstract

The quest to clone the genes encoding the T cell antigen receptor (TCR) was a tale akin to Lewis Carroll's "The Hunting of the Snark". After a long and often frustrating search, back-to-back papers reporting the discovery of the genes encoding the mouse and human TCR were finally published in the March 8, 1984 edition of Nature. In this account, I outline how my laboratory hunted the human form of the Snark, and what our discovery meant to both the immunology community and me personally. Since the isolation of the TCR genes 23 years ago, more than 30,000 papers have been published on subjects as varied as central tolerance, peripheral tolerance, TCR crystal structure, and how TCR bind to peptide/MHC structures. Numerous clinical studies involving aspects of TCR biology have also been reported. Here, I briefly discuss how the knowledge generated from our discovery has been applied to basic and clinical immunology, and where it might take us in the future.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17972349     DOI: 10.1002/eji.200737443

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

1.  Profile of Tak Wah Mak.

Authors:  Jennifer Viegas
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-11       Impact factor: 11.205

Review 2.  T cell costimulation, checkpoint inhibitors and anti-tumor therapy.

Authors:  Dipankar Nandi; Sanmoy Pathak; Taru Verma; Madhulika Singh; Avik Chattopadhyay; Samriddhi Thakur; Abinaya Raghavan; Abhijeet Gokhroo
Journal:  J Biosci       Date:  2020       Impact factor: 1.826

3.  A new approach to simultaneously quantify both TCR α- and β-chain diversity after adoptive immunotherapy.

Authors:  Minying Zhang; Sourindra Maiti; Chantale Bernatchez; Helen Huls; Brian Rabinovich; Richard E Champlin; Luis M Vence; Patrick Hwu; Laszlo Radvanyi; Laurence J N Cooper
Journal:  Clin Cancer Res       Date:  2012-07-03       Impact factor: 12.531

Review 4.  Recent advances in cancer immunotherapy.

Authors:  Qiang Sun; Gerry Melino; Ivano Amelio; Jingting Jiang; Ying Wang; Yufang Shi
Journal:  Discov Oncol       Date:  2021-08-18

5.  Positioning of autoimmune TCR-Ob.2F3 and TCR-Ob.3D1 on the MBP85-99/HLA-DR2 complex.

Authors:  Zenichiro Kato; Joel N H Stern; Hironori K Nakamura; Kazuo Kuwata; Naomi Kondo; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-29       Impact factor: 11.205

Review 6.  Dendritic cells for active anti-cancer immunotherapy: targeting activation pathways through genetic modification.

Authors:  Karine Breckpot; David Escors
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2009-12       Impact factor: 2.895

7.  Extralymphocytic flexible immune recognition: a new angle on inflammation and aging.

Authors:  Wolfgang E Kaminski; Alexander W Beham; Kerstin Puellmann
Journal:  Aging Dis       Date:  2012-09-19       Impact factor: 6.745

8.  Rational development of high-affinity T-cell receptor-like antibodies.

Authors:  Guillaume Stewart-Jones; Andreas Wadle; Anja Hombach; Eugene Shenderov; Gerhard Held; Eliane Fischer; Sascha Kleber; Natko Nuber; Frank Stenner-Liewen; Stefan Bauer; Andrew McMichael; Alexander Knuth; Hinrich Abken; Andreas A Hombach; Vincenzo Cerundolo; E Yvonne Jones; Christoph Renner
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-23       Impact factor: 11.205

Review 9.  PD-1, PD-L1 (B7-H1) and Tumor-Site Immune Modulation Therapy: The Historical Perspective.

Authors:  Jun Wang; Ruirong Yuan; Wenru Song; Jingwei Sun; Delong Liu; Zihai Li
Journal:  J Hematol Oncol       Date:  2017-01-25       Impact factor: 17.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.